Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

NYSE:BIO  
539.92
+1.08 (+0.20%)
Other Pre-Announcement

Bio-Rad Reports Second-Quarter 2022 Financial Results

Published: 07/28/2022 21:20 GMT
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A (BIO) - Bio-rad Reports Second-quarter 2022 Financial Results.
Bio Rad Laboratories Inc - Second-quarter 2022 Net Sales Were $691.1 Million, a Decrease of 3.5 Percent Compared to $715.9 Million Reported for Q2 of 2021.
Bio Rad Laboratories Inc - Net Loss for Q2 of 2022 Was $927.2 Million, Or a Loss of $31.12 per Share, on a Diluted Basis.
Bio Rad Laboratories Inc - Non-GAAP Net Income for Q2 of 2022 Was $101.4 Million, Or $3.38 per Share.
Bio Rad Laboratories Inc - Sees FY Non-GAAP Currency-neutral Revenue Growth to Be at High End of Prior 1.0 to 2.0 Percent Guidance.